...passing, too terribly soon, I have thought many times of a quote often attributed to Maya...

...U.S. Pharmaceuticals at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) at year end. He will be replaced by Maya...

...MD Anderson Cancer Center Vivace Therapeutics Large tumor suppressor homolog 1 (LATS1) LATS large tumor suppressor homolog 2 (LATS2) MST1/2-antagonizing for YAP activation (MAYA) Yes-associated...

...cancer Cell culture and mouse studies suggest inhibiting ROR1 or the long non-coding RNA (lncRNA) MAYA...
...ROR1 knockout or MAYA knockdown decreased proliferation, migration and invasiveness compared with normal ROR1 and MAYA...
...or a locked nucleic acid (LNA) targeting MAYA decreased metastatic tumor burden compared with normal MAYA...

...application filed; licensing details available from The University of Chicago and the University of Pittsburgh Herazo-Maya...

...published online May 8, 2011; doi:10.1038/nature09982 Contact: Maya Saleh, McGill University, Montreal, Quebec, Canada e-mail: maya.saleh@mcgill.ca BC...

...June 18, 2009; doi:10.1016/j.immuni.2009.04.011 Contact: Maya Saleh, McGill University Life Sciences Complex, Quebec, Canada e-mail: maya.saleh@mcgill.ca...

...with El Colegio de la Frontera Sur (San Cristobal de Las Casas, Mexico) and local Maya...